Community acquired bacterial pneumonia

@article{Anevlavis2010CommunityAB,
  title={Community acquired bacterial pneumonia},
  author={S. Anevlavis and Demosthenes Bouros},
  journal={Expert Opinion on Pharmacotherapy},
  year={2010},
  volume={11},
  pages={361 - 374}
}
  • S. Anevlavis, Demosthenes Bouros
  • Published 2010
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • Importance of the field: Community-acquired pneumonia (CAP) is a common and potentially life-threatening illness that continues to be a major medical problem. Among infectious diseases, CAP is the leading cause of death in the world and is associated with a substantial economic burden to health are systems around the globe. Areas covered in this review: Recently identified clinical and biochemical tools promise to improve the assessment of CAP severity. Various prognostic scoring systems and… CONTINUE READING

    Paper Mentions

    Diagnosis of Pneumococcal Pneumonia: Current Pitfalls and the Way Forward
    • 51
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 143 REFERENCES
    A prediction rule to identify low-risk patients with community-acquired pneumonia.
    • 2,868
    Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.
    • 1,326
    Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    • 774
    • PDF
    Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
    • 3,398
    • PDF